Atom | Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)

Funder: National Institutes of Health

Due Dates: February 28, 2025 (New/Renewal/Resubmission/Revision) | May 7, 2025 (AIDS) | October 28, 2025 (New/Renewal/Resubmission/Revision) | January 7, 2026 (AIDS)

Funding Amounts: Up to $75,000 direct costs per year, max 2 years (R21 mechanism); no clinical trials allowed.

Summary: Supports secondary analysis of existing human datasets to advance research in heart, lung, blood diseases, and sleep disorders within the NHLBI mission.

Key Information: No new primary data collection permitted; applications exceeding $75,000/year direct costs will not be reviewed.

Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)

Sign in to see full grant listing